A Patient-Oriented Research Mentoring Program in Tobacco Dependence and Implementation Science Research

Launched by ABRAMSON CANCER CENTER AT PENN MEDICINE · May 1, 2023

Keywords

ClinConnect Summary

Treatments for tobacco use, including behavioral counseling and FDA-approved medications, increase the likelihood that smokers interested in quitting will make and succeed in a quit attempt. These medications are safe, including among smokers with psychiatric and medical comorbidities, including cancer, HIV, and cardiovascular disease. Yet, the majority of smokers who try to quit do not use FDA-approved medications or guideline-based counseling in their attempt. Data from Medicaid, Medicare, outpatient medical settings, and primary care show that, at best, only 25% of those interested in qu...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• * Clinician participants must meet the following criteria for enrollment:
• • 1. Penn Division of Infectious Disease
• • 2. Prescribing authority in Pennsylvania (i.e., physician, nurse practitioner, physician assistant)
• • 3. Clinical oversight of HIV patients for the past six months
• • 4. English-speaking (messages will be in English)
• • Patient participants must be diagnosed with HIV and report current tobacco smoking (self-report daily smoking for last 6 months)